32 pending office actions • 20 clients • 29 examiners • 22 art units • 0 of 32 (0%) have an AI response strategy ready
Based on the USPTO statutory response window for each pending office action. 12 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Every pending office action with a known statutory deadline, placed on a days-until-due axis. Dots left of Today are overdue; the further right, the more runway. Cases that share a deadline window stack vertically. 12 of the docket's apps have a known mailing date.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 only | 2 (6%) |
| §101 + other | 2 (6%) |
| §103 only | 10 (31%) |
| §102 only | 1 (3%) |
| §112 only | 4 (12%) |
| Double-patenting only | 1 (3%) |
| Multi-statute (no §101) | 12 (38%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| KRAISINGER, EMILY MARIE | 2 | 31.1% | +44.0% |
| HERON, VELVET ELIZABETH | 2 | 42.9% | +57.8% |
| BAKSHI, PANCHAM | 2 | 77.0% | +30.2% |
| DEERY, ERIN LEAH | 1 | 58.4% | +49.0% |
| WRUBLESKI, MATTHEW JAMES | 1 | 59.8% | +59.4% |
| AMICK, THOMAS RUSSE | 1 | 72.6% | +31.1% |
| SODERQUIST, ARLEN | 1 | 59.8% | +26.5% |
| VALLE, ERNESTO | 1 | 56.0% | +41.3% |
| OLSON, ANDREA STEFFEL | 1 | 62.2% | -11.9% |
| LUSI, ELLIS FOLLETT | 1 | 64.3% | +52.8% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18002537 | Blood Sampling Device and Method for PEth Measurement | HERON, VELVET ELIZABETH | 46d overdue |
| 18554006 | TREATMENT OF VIRUS INFECTIONS | OLSON, ANDREA STEFFEL | 32d overdue |
| 18246569 | TREATMENT OF MUSCLE ATROPHY USING DEXTRAN SULFATE | BAKSHI, PANCHAM | 32d overdue |
| 18005757 | METHODS AND COMPOSITIONS FOR TREATMENT OF FRAGILE X SYNDROME | BATES, KEENAN ALEXANDER | 23d |
| 19061380 | Toilet Training Seat | DEERY, ERIN LEAH | — |
| 18953885 | LANGUAGE MODEL-ASSISTED CONTENT COMPLIANCE ANALYSIS SYSTEM | KRAISINGER, EMILY MARIE | — |
| 18953799 | AUTOMATED COMPLIANCE VERIFICATION OF REGULATED CONTENT ITEMS IN A CONTENT PAGE | KRAISINGER, EMILY MARIE | — |
| 18577441 | IMPROVEMENTS IN OR RELATING TO A METHOD OR AN APPARATUS FOR DETECTING AN INTERACTION BETWEEN A BIOLOGICAL ENTITY AND A MOLECULE | SODERQUIST, ARLEN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 8 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18002537 | Blood Sampling Device and Method for PEth Measurement | HERON, VELVET ELIZABETH | 46d overdue |
| 18246569 | TREATMENT OF MUSCLE ATROPHY USING DEXTRAN SULFATE | BAKSHI, PANCHAM | 32d overdue |
| 19061380 | Toilet Training Seat | DEERY, ERIN LEAH | — |
| 18953885 | LANGUAGE MODEL-ASSISTED CONTENT COMPLIANCE ANALYSIS SYSTEM | KRAISINGER, EMILY MARIE | — |
| 18953799 | AUTOMATED COMPLIANCE VERIFICATION OF REGULATED CONTENT ITEMS IN A CONTENT PAGE | KRAISINGER, EMILY MARIE | — |
| 18681294 | TAMPON INSERTION DEVICE AND METHOD | WRUBLESKI, MATTHEW JAMES | — |
| 18578381 | DIFFERENTIAL CXCR4 EXPRESSION ON HEMATOPOIETIC PROGENITOR CELLS VERSUS STEM CELLS DIRECTS HOMING AND LONG-TERM ENGRAFTMENT | AMICK, THOMAS RUSSE | — |
| 18577441 | IMPROVEMENTS IN OR RELATING TO A METHOD OR AN APPARATUS FOR DETECTING AN INTERACTION BETWEEN A BIOLOGICAL ENTITY AND A MOLECULE | SODERQUIST, ARLEN | — |
| Art Unit | Apps |
|---|---|
| 1623 | 3 |
| 1798 | 3 |
| 1797 | 3 |
| 3626 | 2 |
| 1638 | 1 |
| 1693 | 1 |
| 1636 | 1 |
| 1663 | 1 |
| 1758 | 1 |
| 1774 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19061380 | Toilet Training Seat | Mykidzy LLC | DEERY, ERIN LEAH | §103§112 | Non-Final OA | — | Pending | Feb 24, 2025 | |
| 18953885 | LANGUAGE MODEL-ASSISTED CONTENT COMPLIANCE ANALYSIS SYSTEM | Complyauto Ip LLC | KRAISINGER, EMILY MARIE | 3626 | §101 | Final Rejection | — | Pending | Nov 20, 2024 |
| 18953799 | AUTOMATED COMPLIANCE VERIFICATION OF REGULATED CONTENT ITEMS IN A CONTENT PAGE | Complyauto Ip LLC | KRAISINGER, EMILY MARIE | 3626 | §101§103 | Final Rejection | — | Pending | Nov 20, 2024 |
| 18681294 | TAMPON INSERTION DEVICE AND METHOD | Tina Holdings, LLC | WRUBLESKI, MATTHEW JAMES | DP | Non-Final OA | — | Pending | Feb 05, 2024 | |
| 18578381 | DIFFERENTIAL CXCR4 EXPRESSION ON HEMATOPOIETIC PROGENITOR CELLS VERSUS STEM CELLS DIRECTS HOMING AND LONG-TERM ENGRAFTMENT | Children'S Hospital Medical Center | AMICK, THOMAS RUSSE | 1638 | §102 | Non-Final OA | — | Pending | Jan 11, 2024 |
| 18577441 | IMPROVEMENTS IN OR RELATING TO A METHOD OR AN APPARATUS FOR DETECTING AN INTERACTION BETWEEN A BIOLOGICAL ENTITY AND A MOLECULE | Lightcast Discovery Ltd. | SODERQUIST, ARLEN | §102§103§112 | Non-Final OA | — | Pending | Jan 08, 2024 | |
| 18573570 | NEW USE OF MONENSIN | Marco Maccarana | VALLE, ERNESTO | 1623 | §102§103§112 | Non-Final OA | — | Pending | Dec 22, 2023 |
| 18554006 | TREATMENT OF VIRUS INFECTIONS | Tx Medic AB | OLSON, ANDREA STEFFEL | 1693 | §103§112 | Non-Final OA | 32d overdue | Pending | Oct 05, 2023 |
| 18282396 | METHOD OF SELECTING CELLS | Lightcast Discovery Ltd. | LUSI, ELLIS FOLLETT | 1636 | §112 | Non-Final OA | — | Pending | Sep 15, 2023 |
| 18263146 | METHOD OF PROVIDING BROAD-SPECTRUM RESISTANCE TO PLANTS, AND PLANTS THUS OBTAINED | Naga Charan Konakalla | ORDAZ, CHRISTIAN JOSE | 1663 | §112 | Final Rejection | 97d overdue | Pending | Jul 27, 2023 |
| 18252813 | REFINED USES OF GABA A RECEPTOR MODULATORS IN TREATMENT OF FRAGILE X SYNDROME | Children'S Hospital Medical Center | WHITE, DENNIS MICHAEL | 1758 | §102§103Other | Final Rejection | — | Pending | May 12, 2023 |
| 18030136 | IMPROVEMENTS IN OR RELATING TO A DEVICE AND METHODS FOR FACILITATING MANIPULATION OF MICRODROPLETS | Lightcast Discovery Ltd. | HERON, VELVET ELIZABETH | 1798 | §102§103 | Final Rejection | — | Pending | Apr 04, 2023 |
| 18030132 | IMPROVEMENTS IN OR RELATING TO A DEVICE AND METHODS FOR FACILITATING MANIPULATION OF MICRODROPLETS | Lightcast Discovery Ltd. | MUI, CHRISTINE T | 1797 | §103§112 | Final Rejection | — | Pending | Apr 04, 2023 |
| 18246569 | TREATMENT OF MUSCLE ATROPHY USING DEXTRAN SULFATE | Tx Medic AB | BAKSHI, PANCHAM | 1623 | §102§103§112Other | Non-Final OA | 32d overdue | Pending | Mar 24, 2023 |
| 18109074 | SYSTEM FOR SYSTEM FOR PREPARING HIGH-PURITY TAURINE AND SALT | Qianjiang Yongan Pharmaceutical Co. Ltd. | KUYKENDALL, ALYSSA LEE | 1774 | §103 | Non-Final OA | 79d overdue | Pending | Feb 13, 2023 |
| 18040074 | CALCIUM-DEFICIENT SILICATE-SUBSTITUTED CALCIUM PHOSPHATE APATITE COMPOSITIONS AND METHODS | Ossdsign AB | LIU, TRACY | 1614 | §103 | Non-Final OA | 70d | Pending | Jan 31, 2023 |
| 18006745 | PREDICTING CANCER RELAPSE AND TREATMENT OF CANCER DISEASES | Fredrik Johansson Swartling | KOVACH, KARA NICOLE | 1681 | §103 | Final Rejection | 41d | Pending | Jan 25, 2023 |
| 18005757 | METHODS AND COMPOSITIONS FOR TREATMENT OF FRAGILE X SYNDROME | Forge Biologics, Inc. | BATES, KEENAN ALEXANDER | 1631 | §102§103 | Non-Final OA | 23d | Pending | Jan 17, 2023 |
| 18002537 | Blood Sampling Device and Method for PEth Measurement | Capitainer AB | HERON, VELVET ELIZABETH | 1798 | §102§103 | Non-Final OA | 46d overdue | Pending | Dec 20, 2022 |
| 18002526 | Functionalized Blood Sampling Device and Method for PEth Measurement | Capitainer AB | GZYBOWSKI, MICHAEL STANLEY | 1798 | §103 | Final Rejection | 147d overdue | Pending | Dec 20, 2022 |
| 18067211 | SENSOR UNIT, MEASURING METHOD AND PRODUCTION METHOD | Presens Precision Sensing GmbH | GERIDO, DWAN A | 1797 | §102§103§112 | Non-Final OA | — | Pending | Dec 16, 2022 |
| 17958287 | SYSTEM AND METHOD TO ENGINEER USER EXPERIENCE | Cigniti Technologies Limited | MORSHED, HOSSAIN M | 2191 | §101 | Final Rejection | — | Pending | Sep 30, 2022 |
| 17794286 | PREDICTING PATIENT SURVIVAL | Arocell AB | DUNN, MCKENZIE A | 1678 | §103 | Non-Final OA | — | Pending | Jul 21, 2022 |
| 17858296 | MICROFLUIDIC DEVICES | Capitainer AB | GERHARD, ALISON CLAIRE | 1797 | §103 | Non-Final OA | — | Pending | Jul 06, 2022 |
| 17785455 | PLATELET CONCENTRATE CONTROL | Cyteguard AB | CHOWDHURY, TARIFUR RASHID | 2877 | §103 | Final Rejection | — | Pending | Jun 15, 2022 |
| 17776644 | PEG-LIPID | Icoat Medical AB | BAKSHI, PANCHAM | 1623 | §103 | Non-Final OA | — | Pending | May 13, 2022 |
| 17767730 | METHOD AND APPARATUS FOR CLINICAL TESTING | Lightcast Discovery Ltd. | AFREMOVA, VERA | 1653 | §103§112 | Non-Final OA | — | Pending | Apr 08, 2022 |
| 17642510 | IN VITRO FERTILISATION (IVF) EMBRYO VIABILITY AND QUALITY ASSAY | UNIVERSITY OF TARTU | BAUSCH, SARAE L | 1699 | §101§102§112 | Final Rejection | — | Pending | Mar 11, 2022 |
| 17625527 | NOVEL BSSL ANTIBODIES | Lipum AB | AEDER, SEAN E | 1642 | §112 | Non-Final OA | 23d overdue | Pending | Jan 07, 2022 |
| 17603774 | VIRAL VECTOR MANUFACTURING METHODS | Children'S Hospital Medical Center | JADHAO, SAMADHAN JAISING | 1672 | §103Other | Final Rejection | 8d | Pending | Oct 14, 2021 |
| 17432656 | METHODS AND COMPOSITIONS FOR THE DETECTION, CLASSIFICATION, AND DIAGNOSIS OF CHRONIC POST-SURGICAL PAIN | Children'S Hospital Medical Center | SISSON, BRADLEY L | 1682 | §112 | Final Rejection | 15d overdue | Pending | Aug 20, 2021 |
| 17297112 | EX VIVO ORGAN TREATMENT WITH PEG-PHOSPHOLIPID MOLECULES | Icoat Medical AB | BEHARRY, ZANNA MARIA | 1632 | §103 | Final Rejection | — | Pending | May 26, 2021 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial